Ana María García Vicente1*, Laura García Zoghby1, Nicolás Mohedano Mohedano2, Fernando Leal Hernández3 and Ángel Soriano Castrejón1
1Department of Nuclear Medicine, Hospital General Universitario de Ciudad Real, Spain 2Department of Oncology, Hospital General Universitario de Guadalajara, Spain 3Department of Urology, Hospital General Universitario de Guadalajara, SpainFulltext PDF
The small cell neuroendocrine variant is a rare subset of prostate cancer. We present the case of a patient who underwent a dual tracer 18F-Fluorocholine and 18F-DCFPyL PET/CT in the context of biochemical recurrence. Completely discordant results were found using both radiotracers, defining the biological heterogeneity in tumor expression and treatment response.
18F-Fluorocholine; 18F-DCFPyL; PET/CT; Small cell neuroendocrine prostate cancer; Dual tracer
Garcia Vicente AM, Garcia Zoghby L, Mohedano Mohedano N, Leal Hernandez F, Soriano Castrejón A. Dual Tracer 18F-Fluorocholine and 18FDCFPyL PET/CT in the Assessment of a Small Cell Neuroendocrine Transformation of Metastatic Prostate Cancer. Ann Clin Case Rep. 2021; 6:1973..